XCUR (Exicure, Inc. Common Stock) Stock Analysis - AI Report
Exicure, Inc. Common Stock (XCUR) is a publicly traded Healthcare sector company. As of May 21, 2026, XCUR trades at $2.76 with a market cap of $19.50M and a P/E ratio of -3.70. XCUR moved +2.08% today. Year to date, XCUR is -46.89%; over the trailing twelve months it is -70.69%. Its 52-week range spans $2.15 to $36.00. Rallies surfaces XCUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on XCUR?
Rallies AI research for XCUR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Exicure HiTron Inc. sold 258.37K (~$1.16M) on Jan 21, 2026.
Exicure HiTron Inc. sold 734.75K (~$3.31M) on Jan 16, 2026.
Exicure HiTron Inc. sold 741.27K (~$3.34M) on Jan 7, 2026.
XCUR Analyst Consensus
XCUR analyst coverage data. Average price target: $0.00.
Common questions about XCUR
What is the AI research view on XCUR?
Rallies AI research for XCUR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for XCUR?
Rallies AI research for XCUR combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is XCUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XCUR. It does not provide personalized investment advice.
